Decreased plasma protein binding of phenytoin in patients on valproic acid
- PMID: 391256
- PMCID: PMC1429898
- DOI: 10.1111/j.1365-2125.1979.tb01042.x
Decreased plasma protein binding of phenytoin in patients on valproic acid
Abstract
1 Plasma protein binding of phenytoin and of valproic acid were measured in ten epileptic patients on this drug combination. Ten other epileptics not on valproic acid served as controls. All patients had normal kidney function. 2 The measured free fraction of phenytoin among the patients on valproic acid ranged from 12.5 to 23.2% and after recalculation to a plasma albumin level of 45 g/l from 12.5 to 20.0 (median 15.4%). This differed significantly (P = 0.002, Mann- Whitney U-test) from the control patients where the normalized values ranged from 9.9 to 13.9% with a median value of 11.8%. 3 The measured free fractions of phenytoin and of valproic acid showed a significant correlation which, however, was due to the quantitative relation between the degree of binding of both these drugs and the concentration of plasma albumin. There was no discernable relation in this material between the free concentration of valproic acid and the free fraction of phenytoin. 4 It is concluded that patients on combined treatment with phenytoin and valproic acid have an unpredictably raised free fraction of phenytoin. This drug interaction therefore can complicate the important plasma level monitoring of phenytoin in epileptic patients unless the free concentration of this drug can be analysed or estimated.
Similar articles
-
Effect of valproate on free plasma phenytoin concentrations.Br J Clin Pharmacol. 1984 Jul;18(1):17-20. doi: 10.1111/j.1365-2125.1984.tb05015.x. Br J Clin Pharmacol. 1984. PMID: 6430316 Free PMC article.
-
The quantitative effect of serum albumin, serum urea, and valproic acid on unbound phenytoin concentrations in children.J Child Neurol. 2014 Jun;29(6):803-10. doi: 10.1177/0883073813486294. Epub 2013 May 13. J Child Neurol. 2014. PMID: 23670246
-
Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.Basic Clin Pharmacol Toxicol. 2006 Aug;99(2):133-40. doi: 10.1111/j.1742-7843.2006.pto_309.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16918714 Clinical Trial.
-
[Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].Fortschr Neurol Psychiatr Grenzgeb. 1978 Jun;46(6):327-41. Fortschr Neurol Psychiatr Grenzgeb. 1978. PMID: 352872 Review. German.
-
Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.Ther Drug Monit. 1980;2(4):331-44. Ther Drug Monit. 1980. PMID: 7013166 Review.
Cited by
-
Therapeutic drug monitoring.Indian J Pediatr. 1986 Mar-Apr;53(2):149-62. doi: 10.1007/BF02748503. Indian J Pediatr. 1986. PMID: 3744455 No abstract available.
-
Effect of valproate on free plasma phenytoin concentrations.Br J Clin Pharmacol. 1984 Jul;18(1):17-20. doi: 10.1111/j.1365-2125.1984.tb05015.x. Br J Clin Pharmacol. 1984. PMID: 6430316 Free PMC article.
-
What is the true clinical significance of plasma protein binding displacement interactions?Drug Saf. 1995 Apr;12(4):227-33. doi: 10.2165/00002018-199512040-00001. Drug Saf. 1995. PMID: 7646820 Review. No abstract available.
-
Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus.J Clin Pharmacol. 2021 Jun;61(6):763-768. doi: 10.1002/jcph.1801. Epub 2021 Jan 12. J Clin Pharmacol. 2021. PMID: 33336359 Free PMC article. Clinical Trial.
-
Protein binding displacement interactions and their clinical importance.Drugs. 1983 May;25(5):495-513. doi: 10.2165/00003495-198325050-00003. Drugs. 1983. PMID: 6345130 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources